Amo-Aparicio, Jesus
Daly, Jonathan
Højen, Jesper Falkesgaard
Dinarello, Charles A.
Funding for this research was provided by:
National Health Research Institutes (AI-15614)
Lundbeck Foundation
OLATEC Therapeutics LLC
Article History
Received: 1 May 2023
Accepted: 11 June 2023
First Online: 22 June 2023
Declarations
:
: Animal protocols were approved by the University of Colorado Animal Care and Use Committee. Protocol number: 000105.
: C.A.D. serves as Chairman of Olatec’s Scientific Advisory Board, is co-Chief Scientific Officer, and receives compensation.